CD19 and primary progressive multiple sclerosis: Whereas no differences were observed when either unstimulated or non-antigenic-stimulated cells were analyzed, results showed that CD19+ cells expressing TNFα were significantly increased in patients with a diagnosis of either PP, SP and RR multiple sclerosis compared to BEMS individuals and HC, with the highest values being present in PPMS patients.